Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels
Clinical trials have demonstrated the safety and efficacy of autologous endothelial progenitor cell (EPC) therapy in various diseases. Since EPCs’ functions are influenced by genetic, systemic and environmental factors, the therapeutic potential of each individual EPCs is unknown and may a...
Main Authors: | Nadin Sabbah, Tal Tamari, Rina Elimelech, Ofri Doppelt, Utai Rudich, Hadar Zigdon-Giladi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/11/717 |
Similar Items
-
The Paracrine Role of Endothelial Cells in Bone Formation via CXCR4/SDF-1 Pathway
by: Tal Tamari, et al.
Published: (2020-05-01) -
Tussilagone Suppresses Angiogenesis by Inhibiting the VEGFR2 Signaling Pathway
by: Jia Li, et al.
Published: (2019-07-01) -
Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease
by: Kevin Kuonqui, et al.
Published: (2023-12-01) -
Coral-Derived Compound WA-25 Inhibits Angiogenesis by Attenuating the VEGF/VEGFR2 Signaling Pathway
by: Shih-Wei Lin, et al.
Published: (2015-02-01) -
Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation
by: Silvia Graziani, et al.
Published: (2022-01-01)